Eco-friendly fabrication of ZnO quantum dots using Brassica rapa (L.): metabolomic profiling and antimicrobial efficacy against foodborne pathogens supported by in-silico insights
Abstract
The growing challenge of drug-resistant pathogens has forced the urgent need for natural and sustainable antimicrobial alternatives. This research explores the green chemistry-based synthesis of zinc oxide quantum dots (ZnO-QDs) employing the ethanolic root extract of Brassica rapa (L.) to assist their formation and stabilization. Characterization of ZnO-QDs confirmed their hexagonal crystalline structure with a nanoscale size (0.8-2.6 nm) and their good stability. GC/MS assay identified β-phenylethyl isothiocyanate and hydroquinone as the main antimicrobial compounds in the essential oil, while LC-ESI-TOF-MS profiling pinpointed the existence of glucosinolates, flavonoids, and phenolic acids as potential active compounds contributing to nanoparticle formation and antimicrobial potential. The combination of B. rapa essential oil and ZnO-QDs exhibited the strongest antibacterial and antifungal activity among the all investigated samples, showing the highest inhibition against Listeria monocytogenes (30.5 mm), Aspergillus niger (20.5 mm), and Fusarium verticillioides (18.2 mm). Molecular docking revealed powerful binding affinities of key phytochemicals to fungal sterol demethylase CYP51B and bacterial DNA gyrase 2, reinforcing their antimicrobial activity. The study's outcomes reveal that B. rapa-derived ZnO-QDs could be a novel, eco-friendly antimicrobial agent for controlling food spoilage bacteria and mycotoxigenic fungi in food products. Future research should focus on…
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.